- ZFN [2]
- CRISPR [3]
I have great hopes in all of them and in fact, my genetic condition [4] has already been fixed in-vitro using both mitoTALENs [5] and ZFN [6].
Exciting times for medicine. Too bad that we have a long, desperate bureaucratic burden ahead.
[1] https://en.wikipedia.org/wiki/Transcription_activator-like_e...
[2] https://en.wikipedia.org/wiki/Zinc_finger_nuclease
[3] https://en.wikipedia.org/wiki/CRISPR
[4] http://www.ninds.nih.gov/disorders/mitochondrial_myopathy/mi...
[5] http://www.nature.com/nm/journal/v19/n9/full/nm.3261.html
[6] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992073/
CRISPR in particular looks promising for editing human embryos, and we may be on the cusp of a post-cancer world with CAR T-Cell Therapy.
One of my coworkers, who has the same cancer as my deceased father, is going for an experimental treatment involving CAR T-Cell therapy.
Unfortunately, there will always be a bureaucratic burden, but I doubt it will restrict the progress of these types of technologies and innovation.
- ZFN [2]
- CRISPR [3]
I have great hopes in all of them and in fact, my genetic condition [4] has already been fixed in-vitro using both mitoTALENs [5] and ZFN [6].
Exciting times for medicine. Too bad that we have a long, desperate bureaucratic burden ahead.
[1] https://en.wikipedia.org/wiki/Transcription_activator-like_e...
[2] https://en.wikipedia.org/wiki/Zinc_finger_nuclease
[3] https://en.wikipedia.org/wiki/CRISPR
[4] http://www.ninds.nih.gov/disorders/mitochondrial_myopathy/mi...
[5] http://www.nature.com/nm/journal/v19/n9/full/nm.3261.html
[6] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992073/